[Skip to Content]

Graduate Studies Faculty

Diana Gilligan, MD/PhD

Diana Gilligan, MD/PhD
Appointed 10/01/10
Women's Health Network
4317 Weiskotten Hall
766 Irving Avenue
Syracuse, NY 13210

315 464-8668

Current Appointments

Hospital Campus

  • Downtown

Clinical Section Affiliations

  • Medicine: Hematology and Oncology
  • Upstate Cancer Center: Medical Oncology

Research Programs and Affiliations

  • Biochemistry and Molecular Biology
  • Biomedical Sciences Program
  • Medicine


Education & Fellowships

  • Fellowship: Duke University Medical Center, 1994, Clinical Fellow, Hematology/Oncology
  • Fellowship: Duke University Medical Center, 1993, Postdoctoral Fellow
  • Fellowship: University of North Carolina Hospitals - Chapel Hill, 1989, Postdoctoral Fellow
  • Residency: North Carolina Memorial Hospital, 1989, Internal Medicine
  • MD/PhD: Albert Einstein College of Medicine, 1985, Anatomy and Structural Biology
  • BA: Radcliffe College, Harvard University, 1976, Biology

Clinical Interests

  • Hematology

Education Interests

  • Teaching hematology to first and second year medical students.

Research Interests

  • My research includes studies of the role of microRNA in development of leukemia.

Specialties & Certification

  • Internal Medicine
  • Hematology

Diseases & Conditions Treated

  • Adult Leukemia
  • Adult Lymphoma
  • Anemia
  • Bleeding Disorders
  • Blood Clots
  • Chronic Lymphocytic Leukemia
  • Hodgkin's Lymphoma
  • Multiple Myeloma


  • Adults


  • Apheresis
  • Blood Transfusion
  • Bone Marrow Aspiration
  • Bone Marrow Biopsy
  • Bone Marrow Transplantation (BMT)
  • Chemotherapy
  • Infusional Therapies
  • Lumbar Puncture
  • Paracentesis
  • Stem Cell Collection Procedures
  • Stem Cell Transplantation
  • Thoracentesis


  • American Society of Hematology (ASH)
  • American Association for Cancer Research (AACR)

Current Hospital Privileges

  • Upstate University Hospital
  • Crouse Hospital


Link to PubMed External Icon (Opens new window. Close the PubMed window to return to this page.)


My research includes studies of the role of microRNA in the progression of acute myeloid leukemia. We are using Nextgen sequencing to profile microRNA from patients with AML or with myeloproliferative disorders that can progress to AML. We have discovered a group of microRNAs that are increased or decreased in patients with AML compared to normal controls. We are continuing to profile patients after induction chemotherapy to determine if the microRNA profile can predict relapse. We are also studying the effects of changes in microRNA expression on cultured leukemic cell lines. This project will lead to better understanding of the targets of the microRNAs and may lead to development of new therapeutics for AML.

Clinical Profile Shortcut: https://www.upstate.edu/findadoc/gilligad
Faculty Profile Shortcut: https://www.upstate.edu/faculty/gilligad